# Effects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal Dysfunction

> **NCT01407900** · PHASE1 · WITHDRAWN · sponsor: **John A. Schirger**

## Conditions studied

- Heart Failure
- Renal Insufficiency

## Interventions

- **DRUG:** CD-NP
- **DRUG:** 5% Dextrose in Water

## Key facts

- **NCT ID:** NCT01407900
- **Lead sponsor:** John A. Schirger
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-01
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** New technique for administration of drug, this is the old technique of administration.
- **Last updated:** 2014-06-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01407900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01407900, "Effects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal Dysfunction". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01407900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*